Press release -

Oversubscribed Private Placement of €1.42 Million

The Board of Directors of ConceptoMed AS have the pleasure of announcing the successful completion of a private placement of equity in ConceptoMed AS. The share issue was oversubscribed and provided the company with 12 new shareholders. Gross proceeds from the private placement amounted to NOK 11,550,000 (€1.42 Million)

- We are pleased to note the considerable interest in the recently concluded placement in ConceptoMed AS, says CEO Christian Mide.

- In addition to many of the existing shareholders having made use of the opportunity to increase their share of the company, 12 new shareholders have been added to the owner base, says Chairman Sverre Christoffersen. The new shareholders provide the company with a strong owner base with relevant background - which will be involved in lifting the company's activities in future efforts.

ConceptoMed AS has already met considerable interest in the market, and stands before an exciting international development of both Luer-Jack ™ and ConceptoShield ™.

The share issue values ConceptoMed AS at NOK 86.5 million (€10.6 Million).

Topics

  • Business enterprise

Categories

  • medical device
  • needlestick
  • safety syringes
  • syringes and needles market
  • one-hand
  • luer-jack™
  • luer syringes
  • syringes


Contacts

Christian Mide

Press contact CEO +47 95 100720

Related media

Oversubscribed Private Placement of €1.42 Million
  • Oversubscribed Private Placement of €1.42 Million
  • License: Media Use
    The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
  • File format: .pdf
Download
  • Oversubscribed Private Placement of €1.42 Million
  • License: Media Use
    The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
  • File format: .docx
Download

Related content

Runar Bjørklund appointed COB in ConceptoMed AS – Private Placement of €1.05 Million

​The Board of Directors of ConceptoMed AS have the pleasure of announcing the successful completion of a private placement of equity in ConceptoMed AS. Gross proceeds from the private placement amounts to NOK 9.5 Million (€1.05 Million). On Monday 19th of January 2015, Runar Bjørklund, shareholder in ConceptoMed AS and former CFO of Nycomed, was appointed new Chairman of the Board.

ConceptoMed announces Supply Agreement with Becton, Dickinson & Company

ConceptoMed is pleased to announce that it has reached a supply agreement with Becton, Dickinson & Company (BD) – a leading global medical technology company. ConceptoMed will use the different BD syringes in their production of Luer-Jack® - the new generation of medical syringes.